Anti-Listeria mechanisms, safety, and predictive modeling of Lacticaseibacillus casei UTMB9: Probiotic profiling targeting virulence gene expression and biofilm formation

IF 3.5 3区 医学 Q3 IMMUNOLOGY
Pegah Namazi , Behrooz Alizadeh Behbahani , Mohammad Noshad , Alireza Vasiee , Morteza Taki , Hossein Joyandeh
{"title":"Anti-Listeria mechanisms, safety, and predictive modeling of Lacticaseibacillus casei UTMB9: Probiotic profiling targeting virulence gene expression and biofilm formation","authors":"Pegah Namazi ,&nbsp;Behrooz Alizadeh Behbahani ,&nbsp;Mohammad Noshad ,&nbsp;Alireza Vasiee ,&nbsp;Morteza Taki ,&nbsp;Hossein Joyandeh","doi":"10.1016/j.micpath.2025.108071","DOIUrl":null,"url":null,"abstract":"<div><div>There is growing interest in probiotics due to their potential to confer health benefits. This study aimed to explore the potential probiotic characteristics, gene expression linked to biofilm formation, and <em>anti</em>-biofilm properties of <em>Lacticaseibacillus casei</em> UTMB9. <em>L. casei</em> UTMB9 tolerates acidic environments, with survival rates of 6.90, 7.59, and 7.96 log CFU/mL at pH 2.5, 3.5, and 4.5, respectively, and exhibits slight growth inhibition under bile concentrations up to 0.7 %. Viability declined modestly from 8.51 to 6.61 log colony forming unit (CFU)/mL under simulated gastrointestinal conditions. Surface hydrophobicity (40.89 %), auto-aggregation (30.9 %), co-aggregation (40.81 %), and adhesion (11.89 %) support its adherence potential. Antimicrobial assays showed most potent inhibition against <em>Listeria monocytogenes</em> (9.70 mm) versus <em>E. coli</em> (4.74 mm). Scanning Electron Microscopy (SEM) imaging revealed pronounced damage to <em>L. monocytogenes</em> cells after exposure to cell-free supernatant (CFS), accompanied by significant downregulation of <em>prfA</em> and <em>flaA</em>, and marked antibiofilm suppression. It also demonstrated antioxidant activity (2,2-diphenyl-1-picrylhydrazyl (DPPH) 43.58 %, 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) 47.47 %, linoleic acid oxidation inhibition 30.28 %) and moderate anticancer activity (IC<sub>50</sub> ≈ 55–62 mg/mL). The strain reduced cholesterol uptake by 41.9 %, was broadly antibiotic-sensitive (except for partial resistance to ampicillin), and lacked biogenic amine production, DNase, or hemolytic activity. In the second part of this study, Gaussian Process Regression (GPR) was used to predict acidity and bile salt. GPR accurately predicted acidity and bile tolerance (MAPE = 0.22 % and 0.18 %; R<sup>2</sup> ≥ 0.99). These findings position <em>L. casei</em> as a promising probiotic agent with robust antimicrobial, antibiofilm, antioxidant, and predictive model-supported features.</div></div>","PeriodicalId":18599,"journal":{"name":"Microbial pathogenesis","volume":"209 ","pages":"Article 108071"},"PeriodicalIF":3.5000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial pathogenesis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S088240102500796X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

There is growing interest in probiotics due to their potential to confer health benefits. This study aimed to explore the potential probiotic characteristics, gene expression linked to biofilm formation, and anti-biofilm properties of Lacticaseibacillus casei UTMB9. L. casei UTMB9 tolerates acidic environments, with survival rates of 6.90, 7.59, and 7.96 log CFU/mL at pH 2.5, 3.5, and 4.5, respectively, and exhibits slight growth inhibition under bile concentrations up to 0.7 %. Viability declined modestly from 8.51 to 6.61 log colony forming unit (CFU)/mL under simulated gastrointestinal conditions. Surface hydrophobicity (40.89 %), auto-aggregation (30.9 %), co-aggregation (40.81 %), and adhesion (11.89 %) support its adherence potential. Antimicrobial assays showed most potent inhibition against Listeria monocytogenes (9.70 mm) versus E. coli (4.74 mm). Scanning Electron Microscopy (SEM) imaging revealed pronounced damage to L. monocytogenes cells after exposure to cell-free supernatant (CFS), accompanied by significant downregulation of prfA and flaA, and marked antibiofilm suppression. It also demonstrated antioxidant activity (2,2-diphenyl-1-picrylhydrazyl (DPPH) 43.58 %, 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) 47.47 %, linoleic acid oxidation inhibition 30.28 %) and moderate anticancer activity (IC50 ≈ 55–62 mg/mL). The strain reduced cholesterol uptake by 41.9 %, was broadly antibiotic-sensitive (except for partial resistance to ampicillin), and lacked biogenic amine production, DNase, or hemolytic activity. In the second part of this study, Gaussian Process Regression (GPR) was used to predict acidity and bile salt. GPR accurately predicted acidity and bile tolerance (MAPE = 0.22 % and 0.18 %; R2 ≥ 0.99). These findings position L. casei as a promising probiotic agent with robust antimicrobial, antibiofilm, antioxidant, and predictive model-supported features.
干酪乳杆菌UTMB9的抗李斯特菌机制、安全性和预测模型:针对毒力基因表达和生物膜形成的益生菌分析。
由于益生菌具有潜在的健康益处,人们对其越来越感兴趣。本研究旨在探讨干酪乳杆菌UTMB9潜在的益生菌特性、与生物膜形成相关的基因表达以及抗生物膜特性。干酪乳杆菌UTMB9耐受酸性环境,在pH为2.5、3.5和4.5时的存活率分别为6.90、7.59和7.96 log CFU/mL,在胆汁浓度高达0.7%时表现出轻微的生长抑制。在模拟胃肠道条件下,细胞活力从8.51个log菌落形成单位(CFU)/mL略微下降到6.61个。表面疏水性(40.9%)、自聚集性(30.9%)、共聚集性(40.8%)和粘附性(11.9%)支持其粘附潜力。抗菌试验显示,对单核增生李斯特菌(9.70 mm)和大肠杆菌(4.74 mm)的抑制作用最强。扫描电镜(SEM)成像显示,暴露于无细胞上清(CFS)后,单核增生乳杆菌细胞明显受损,prfA和flaA显著下调,抗生素膜明显抑制。具有抗氧化活性(2,2-二苯基-1-吡啶肼(DPPH) 43.6%, 2,2'-氮基-双(3-乙基苯并噻唑-6-磺酸)47.5%,亚油酸氧化抑制30.3%)和中等抗癌活性(IC50≈55-62 mg/mL)。该菌株降低了41.9%的胆固醇摄取,对抗生素广泛敏感(除了对氨苄西林的部分耐药),缺乏生物胺生产、脱氧核糖核酸酶或溶血活性。在本研究的第二部分,采用高斯过程回归(GPR)预测酸度和胆盐。GPR准确预测了酸度和胆汁耐受性(MAPE = 0.22%和0.18%;R2≥0.99)。这些发现表明干酪乳杆菌是一种有前景的益生菌制剂,具有强大的抗菌、抗生物膜、抗氧化和预测模型支持的特点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Microbial pathogenesis
Microbial pathogenesis 医学-免疫学
CiteScore
7.40
自引率
2.60%
发文量
472
审稿时长
56 days
期刊介绍: Microbial Pathogenesis publishes original contributions and reviews about the molecular and cellular mechanisms of infectious diseases. It covers microbiology, host-pathogen interaction and immunology related to infectious agents, including bacteria, fungi, viruses and protozoa. It also accepts papers in the field of clinical microbiology, with the exception of case reports. Research Areas Include: -Pathogenesis -Virulence factors -Host susceptibility or resistance -Immune mechanisms -Identification, cloning and sequencing of relevant genes -Genetic studies -Viruses, prokaryotic organisms and protozoa -Microbiota -Systems biology related to infectious diseases -Targets for vaccine design (pre-clinical studies)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信